Weed IncOTCQB:BUDZ
- LAST PRICE0.0670
- TODAY'S CHANGE (%)0.0010 (1.5152%)
- Bid / Lots0.0640/ 100
- Ask / Lots0.0700/ 140
- Open / Previous Close0.0660 / 0.0660
- Day Range
- 52 Week Range
- Volume31,383
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BUDZ |
|---|---|---|
| 10:24 ET | 5000 | 0.066 |
| 10:26 ET | 9970 | 0.066 |
| 10:30 ET | 15027 | 0.067 |
| 11:04 ET | 160 | 0.064 |
| 11:15 ET | 100 | 0.064 |
| 02:15 ET | 480 | 0.068 |
| 03:00 ET | 520 | 0.067 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Weed Inc | 8.1M | -7.0x | --- |
Check Cap Ltd | 7.9M | -1.4x | --- |
ProtoKinetix Inc | 8.4M | -4.6x | --- |
Qsam Biosciences Inc | 7.9M | -0.7x | --- |
OncoSec Medical Inc | 7.8M | -0.1x | --- |
ENDRA Life Sciences Inc | 8.5M | -0.6x | --- |
Company Information
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage, and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both pharma and non-pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. Its first business opportunity is through its wholly owned subsidiary, Sangre AT, LLC (Sangre), where it is focused on the development and application of cannabis-derived compounds for the treatment of human disease and animal ailments.
Contact Information
- Headquarters
- 4920 N Post TrlTUCSON, AZ, United States 85750-7111
- Phone
- 610-358-9430
- Fax
- 610-358-9438
Executives
- President, Chief Executive Officer, Chief Financial Officer, Director
- Glen Martin
- Secretary, Treasurer, Director
- Nicole Breen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 123.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.53 |
EPS | $-0.01 |
Book Value | $0.01 |
P/E Ratio | -7.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
